Innovative microfluidics test system developer seeks investor

The company has been successfully positioned in the market for over two decades and is one of the leading independent specialists in IT sourcing, cloud transformation, and IT benchmarking in the DACH region. It supports internationally active corporations and large mid-market companies in the planning, tendering, and implementation of complex IT transformation projects—ranging from traditional outsourcing initiatives to modern cloud and business transformation programs. Thanks to its independent market position, in-depth methodological expertise, and a broad network at the decision-maker level, the company possesses a strong unique selling proposition. In addition to its consulting expertise, it offers proprietary analysis tools, benchmark databases, and licensed methodologies that foster long-term customer loyalty and enable scalable revenue. Below, we present the company’s key metrics: Growth opportunities through cloud transformation, AI integration, and digital operating models Employees: 10–20 Long-standing client relationships with DAX-listed corporations and international blue-chip clients Location: D-A-CH The company offers significant growth potential—particularly through the expansion of its service portfolio, strategic partnerships, and the expansion of its international presence.

The company is a technology leader in the field of hypoxia training, specializing in the development, distribution, and servicing of innovative Interval Hypoxia-Hyperoxia Therapy (IHHT) and CO₂ systems. It serves a wide range of sectors, including medicine, therapy, fitness, wellness, and the consumer market, and has established itself as a leader in its field through its customer-focused innovation and technical expertise. With its focus on high-quality product solutions and a comprehensive range of services, the company distinguishes itself through its ability to support both individual clients and institutional customers with customized and effective therapeutic approaches.

Based in North Rhine-Westphalia, the company has made a name for itself over two decades in the trade of specialized medical products. With an established base of existing customers who account for 95% of its revenue, the company demonstrates excellent customer loyalty and stability in the medical device market. Its strength lies in the planning, project management, and sale of these products, with hospitals, medical care centers (MVZ), private practices, and specialty retailers forming the core of its client base. Through its focus on specialized medical needs, the company delivers significant added value and continuously taps into new opportunities in a critical sector.

The company, known under the trading name "ELEVATOR," has established itself as one of the leading suppliers in the technical trading sector and primarily serves the machinery and plant engineering industry with a diverse range of merchandise as well as products developed in-house. With impressive revenue of 6.5 million euros in 2022 and EBIT of 0.7 million euros, the Germany-based company demonstrates not only its financial strength but also its ability to consistently operate at the forefront of a dynamic market. Key factors behind its success include in-depth market knowledge, efficient logistics processes, and a strong focus on customer needs, which make “ELEVATOR” an attractive partner for a broad customer base.

The company is a recognized player in the medical technology sector, distinguished by four decades of continuous market presence and its location in the state of Baden-Württemberg. Specializing in the development and production of devices for therapeutic applications, the company has built up a loyal customer base and a strong brand. Its value creation is driven by in-depth expertise in medical technology, as well as by constant innovation and the quality of its products.